Sonic Healthcare Limited

As of June 30, 2025, Sonic Healthcare Limited carries a market capitalization of 7.00B, placing it among publicly traded companies globally. Its enterprise value stands at 9.42B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Sonic Healthcare Limited's next confirmed earnings release is scheduled for February 22, 2027.

As of June 30, 2025, Sonic Healthcare Limited has 480.40M shares outstanding.

As of June 30, 2025, Sonic Healthcare Limited trades at a trailing price-to-earnings ratio of 26.11. The price-to-sales ratio is 1.39, and the price-to-book ratio stands at 1.61.

As of June 30, 2025, Sonic Healthcare Limited trades at an EV/EBITDA multiple of 10.50 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.88 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 19.96 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 9.42B versus a market cap of 7.00B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2025, Sonic Healthcare Limited maintains a current ratio of 1.17, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 61.03, indicating elevated leverage, while an interest coverage ratio of 14.51 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2025, Sonic Healthcare Limited posted a return on equity (ROE) of 6.32, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 4.52 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 2.71, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 3.94, useful for judging operating efficiency across full business cycles. The company generates approximately 116,697.79 in revenue per employee across its workforce of 43,000.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 4.85 indicates how many times Sonic Healthcare Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2025, Sonic Healthcare Limited recorded 107.96M in income tax expense. That works out to an effective tax rate of 27.56, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 391.70M, leaving 267.93M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on July 20, 2026, Sonic Healthcare Limited's stock has declined approximately 24.88% over the past 52 weeks.

Over the twelve months ended June 30, 2025, Sonic Healthcare Limited generated 5.02B in revenue and converted that into 267.93M in net income, yielding earnings per share of 0.59. EBITDA reached 897.51M, while operating income came in at 472.16M.

As of June 30, 2025, Sonic Healthcare Limited holds 351.48M in cash and equivalents against 2.70B in total debt, resulting in a net debt position of 1.47B. Total book value stands at 4.34B, with working capital of 199.39M providing operational flexibility.

These figures cover the twelve months ended June 30, 2025.

Over the twelve months ended June 30, 2025, Sonic Healthcare Limited posted a gross margin of 83.76, reflecting its pricing power and cost economics. The operating margin of 9.41 and net profit margin of 5.34 provide insight into operational efficiency.

Over the twelve months ended June 30, 2025, Sonic Healthcare Limited paid dividends of 0.62 per share. The dividend payout ratio of 98.70 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 5.49, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Sonic Healthcare Limited shareholders.

As of June 30, 2025, Sonic Healthcare Limited has an Altman Z-Score of 3.93, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.